Phase II Multicenter Study of the Antiepidermal Growth Factor Receptor Monoclonal Antibody Cetuximab in Combination With Platinum-Based Chemotherapy in Patients With Platinum-Refractory Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckJosé Baselga, A. Eckardt, Pere Gascón et al.|Journal of Clinical Oncology|2005Cited by 491
Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorU. Vanhoefer, José Baselga, Mitra Tewes et al.|Journal of Clinical Oncology|2003Cited by 259
New systemic frontline treatment for metastatic colorectal carcinomaAda Braun, P. Preusser, A. Harstrick et al.|Cancer|2004Cited by 71